Literature DB >> 7966624

Differential response of human cells to deletions and stop codons in the gamma(1)34.5 gene of herpes simplex virus.

J Chou1, A P Poon, J Johnson, B Roizman.   

Abstract

Earlier studies have shown that herpes simplex virus mutants lacking the gamma(1)34.5 gene are totally avirulent on intracerebral inoculation of the virus into mice and induce premature shutoff of protein synthesis in human neuroblastoma (SK-N-SH) cells but not in Vero cells. We report the following. (i) Whereas deletion mutant R3616, lacking 1,000 bp of the gamma(1)34.5 gene, caused premature shutoff of protein synthesis in both SK-N-SH and human foreskin fibroblasts (HFF), mutants R4009 and R930 (mutant F), carrying stop codons in all six frames, 27 and 210 codons from the initiation codon of the gamma(1)34.5 genes, respectively, induced shutoff of protein synthesis in SK-N-SH cells but not in HFF. The differences in behavior between the R3616 deletion and R4009 stop codon mutants cannot be attributed to differences in the rate of induction of premature shutoff of protein synthesis and the multiplicity of infection. HFF do not produce detectable truncated gamma(1)34.5 protein or truncated mRNA. (ii) Some clonal lines of SK-N-SH cells carrying a gamma(1)34.5 gene driven by a metallothionein promoter express the gamma(1)34.5 gene constitutively and do not require induction by cadmium to complement the gamma(1)34.5- virus. One clonal cell line complements the gamma(1)34.5- virus only after induction by cadmium. These results are consistent with previous conclusions that the phenotype of premature shutoff of protein synthesis is associated with absence of the gamma(1)34.5 protein and indicate that the amounts of gamma(1)34.5 protein necessary to complement the gamma(1)34.5- viruses are small. We conclude that human cells differ in the manner in which they respond to the presence of stop codons. Shutoff of protein synthesis in HFF infected with the stop codon mutants could have been precluded by small amounts of gamma(1)34.5 protein produced by splicing out of an intron containing the stop codon, downstream initiation of translation, or tRNA suppression of the stop codon.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966624      PMCID: PMC237299          DOI: 10.1128/JVI.68.12.8304-8311.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Inverted repetitions in the chromosome of herpes simplex virus.

Authors:  P Sheldrick; N Berthelot
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Anatomy of herpes simplex virus DNA. II. Size, composition, and arrangement of inverted terminal repetitions.

Authors:  S Wadsworth; R J Jacob; B Roizman
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

3.  Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants.

Authors:  L S Morse; L Pereira; B Roizman; P A Schaffer
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

4.  The terminal a sequence of the herpes simplex virus genome contains the promoter of a gene located in the repeat sequences of the L component.

Authors:  J Chou; B Roizman
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

5.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

6.  Expression of a herpes simplex virus 1 open reading frame antisense to the gamma(1)34.5 gene and transcribed by an RNA 3' coterminal with the unspliced latency-associated transcript.

Authors:  M Lagunoff; B Roizman
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Structure and role of the herpes simplex virus DNA termini in inversion, circularization and generation of virion DNA.

Authors:  E S Mocarski; B Roizman
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

8.  Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components.

Authors:  G S Hayward; R J Jacob; S C Wadsworth; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

9.  Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage.

Authors:  J Chou; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

10.  Characterization of the herpes simplex virus type 1 strain 17+ neurovirulence gene RL1 and its expression in a bacterial system.

Authors:  E A McKie; R G Hope; S M Brown; A R MacLean
Journal:  J Gen Virol       Date:  1994-04       Impact factor: 3.891

View more
  22 in total

1.  Herpes simplex virus type 1 U(L)34 gene product is required for viral envelopment.

Authors:  R J Roller; Y Zhou; R Schnetzer; J Ferguson; D DeSalvo
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  A herpesvirus ribosome-associated, RNA-binding protein confers a growth advantage upon mutants deficient in a GADD34-related function.

Authors:  M Mulvey; J Poppers; A Ladd; I Mohr
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication.

Authors:  Karen L Mossman; James R Smiley
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Infection of human NT2 cells and differentiated NT-neurons with herpes simplex virus and replication-incompetent herpes simplex virus vectors.

Authors:  J P Weir
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

5.  Suppression of the phenotype of gamma(1)34.5- herpes simplex virus 1: failure of activated RNA-dependent protein kinase to shut off protein synthesis is associated with a deletion in the domain of the alpha47 gene.

Authors:  B He; J Chou; R Brandimarti; I Mohr; Y Gluzman; B Roizman
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Separation of receptor-binding and profusogenic domains of glycoprotein D of herpes simplex virus 1 into distinct interacting proteins.

Authors:  Guoying Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

7.  Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1.

Authors:  Kerrington D Smith; James J Mezhir; Kai Bickenbach; Jula Veerapong; Jean Charron; Mitchell C Posner; Bernard Roizman; Ralph R Weichselbaum
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of gamma(1)34.5 transcripts and latency-associated transcripts.

Authors:  L Y Lee; P A Schaffer
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

9.  Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells.

Authors:  A H Koyama; Y Miwa
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

10.  Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma.

Authors:  R Chambers; G Y Gillespie; L Soroceanu; S Andreansky; S Chatterjee; J Chou; B Roizman; R J Whitley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.